陈德喜-艾滋病研究最新进展.ppt

I will start by reviewing the drugs that have been approved by the US Food and Drug Administration (FDA) for the treatment of HIV therapy. In 2006, we have 21 agents that are available for treatment regimens. There are 8 in the NRTI class, 3 in the NNRTI class, 1 fusion inhibitor, and 10 in the protease inhibitor class that are approved by the FDA. Amprenavir has been withdrawn from the market because the prodrug of amprenavir, fosamprenavir, has been approved and is available. There are also a number of fixed-dose formulations that encompass the 3 class of agents, except the fusion inhibitors